Many in the medical field are hopeful that with the increased accessibility that oral medications offer, patients will have an easier time remaining adherent to their treatment for GLP-1s
Financial assistance programs may help eligible patients
Most users find the hunger increase to be very mild or non-existent
Semaglutide is a glucagon-like peptide agonist and it works by increasing insulin release, blocking glucagon secretion, slowing gastric emptying, and blood glucose control
Evidence and Guidance Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes and weight management
Taking the two together also increases thyroxine absorption by 33%, so they shouldnt be swallowed at the same time